Clinical trial
New Formulation of Semaglutide in the Treatment of Type 2 Diabetes in Argentina: a Prospective, Multicenter, Real-world Study
NCT07621419 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Formulation of Semaglutide in the Treatment of Type 2 Diabetes in Argentina: a Prospective, Multicenter, Real-world Study
- Lead sponsor
- Hospital Italiano de Buenos Aires
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 4, 2025
- Completion date
- December 31, 2028
- Enrollment
- 145 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.